medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Número 01

<< Anterior Siguiente >>

Ginecol Obstet Mex 2020; 88 (01)


Sangrado uterino anormal y PALM COEIN

Sepúlveda-Agudelo J, Sepúlveda-Sanguino AJ

Idioma: Español
Referencias bibliográficas: 58
Paginas: 59-67
Archivo PDF: 244.76 Kb.


RESUMEN

Objetivo: Comunicar la nueva terminología del sangrado uterino anormal y de la clasificación PALM COEIN.
Método: Búsqueda bibliográfica de artículos publicados en inglés o español con la palabra clave PALM COEIN. Desde el primer artículo publicado en 2010 hasta 2018 en las bases de datos MedLine, PubMed, Embase y Ovid.
Resultados: Se reunieron 64 artículos, pero solo 18 mencionaban el término, 24 eran repetidos. Se seleccionaron 22 que trataban el tema en estudio y eran referidos con la clasificación actual, de esos trabajos 6 eran de cohorte, 2 de revisión sistemática, 2 boletines y 12 revisiones de tema.
Conclusión: Esta nueva terminología facilitará el entendimiento y la comunicación, independiente del idioma y la cultura, además del acercamiento más entendible con nuestras pacientes. La clasificación PALM COEIN facilita la investigación epidemiológica, etiológica y el tratamiento de las pacientes con sangrado uterino anormal.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bandi ND, et al. Utility of the PALM-COEIN classification of abnormal uterine bleeding for Indian gynecologists. Int J Gynecol Obstet. 2016; 133: 196-98. doi: 10.1016/j. ijgo.2015.09.030

  2. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 54-65. doi: 10.1016/j.bpobgyn.2015.11.012

  3. Bahamondes L, Ali M. Recent advances in managing and understanding menstrual disorders. Prime Rep. 2015; 7: 33. doi:10.12703/P7-33

  4. Singh S, et al. Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can 2018; 40 (5): e391-e415. doi: 10.1016/j.jogc.2018.03.007

  5. Sepúlveda J, Díaz G. Detención de la hemorragia uterina anormal en pacientes a quienes se realizó histeroscopia operatoria. Ginecol Obstet Mex. 2018; 86 (1): 13-25. doi: 10.24245/gom.v86i1.1666

  6. Fraser IS, et al. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertility and Sterility. 2007; 87 (3): 466-76. doi:10.1016/j.fertnstert. 2007.01.023

  7. Fraser IS, et al. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Human Reproduction 2007; 22: (3): 635-43. doi:10.1093/humrep/del478

  8. Woolcock JG, et al. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008; 90: 2269-80. doi: 10.1016/j.fertnstert.2007.10.060

  9. Bacon JL. Abnormal Uterine Bleeding: Current Classification and Clinical Management. Obstet Gynecol Clin North Am. 2017; 44 (2): 179-93. doi: 10.1016/j.ogc.2017.02.012

  10. Munro MG, et al. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? Am J Obstet Gynecol. 2012; 207 (4): 259-65. doi: 10.1016/j.ajog.2012.01.046

  11. Munro MG. Abnormal uterine bleeding. Cambridge, UK: Cambridge University Press; 2010.

  12. Committee on Practice Bulletins-Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012; 120 (1): 197-206. doi: 10.1097/AOG.0b013e318262e320.

  13. Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011; 95: 2204-8. doi:10.1016/j.fertnstert. 2011.03.079

  14. Munro MG. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 3-22. doi: 10.1016/j.bpobgyn.2016.09.011

  15. American Association of Gynecologic Laparoscopists. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Endometrial Polyps. J Minim Invasive Gynecol. 2012; 19 (1): 3-10. doi:10.1016/j. jmig.2011.09.003

  16. Vigueras A. Escalona JR. Pólipos endometriales: Actualización en diagnóstico y tratamiento. Rev Chil Obstet Ginecol 2016; 81 (2): 152-8.

  17. Clark TJ, Stevenson H. Endometrial polyps and abnormal uterine bleeding (AUB-P): What is the relationship, how are they diagnosed and how are they treated? Best Pract Res Obstet Gynaecol. 2017; 40: 89-104. doi: 10.1016/j. bpobgyn.2016.09.005

  18. Salim S, et al. Diagnosis and Management of Endometrial Polyps: A Critical Review of the Literature. J Minim Invasive Gynecol 2011; 18: 569-81. doi: 10.1016/j.jmig.2011.05.018.

  19. Beal HN, et al. Endometrial cells identified in cervical cytology in women > or 5 40 years of age: criteria for appropriate endometrial evaluation. Am J Obstet Gynecol 2007; 196: 568. e1-5. doi: 10.1016/j.ajog.2007.01.040

  20. Finco A, et al. Surgical management of abnormal uterine bleeding in fertile age women. Women’s Health (Lond). 2015; 11 (4): 513-25. doi: 10.2217/whe.15.12

  21. Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand. 2010; 89: 992-1002. doi: 10.3109/00016349.2010.493196

  22. Deneris A. PALM-COEIN Nomenclature for Abnormal Uterine Bleeding. J Midwifery Womens Health. 2016; 61 (3): 376-9. doi:10.1111/jmwh.12440

  23. Munro MG, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113: 3-13. doi:10.1016/j.ijgo.2010.11.011

  24. Hapangama DK, Bulmer JN. Pathophysiology of heavy menstrual bleeding. Women’s Health 2016; 12 (1): 3-13. doi: 10.2217/whe.15.81

  25. Donnez J, et al. Introduction: Uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. 2018; 109 (3): 369-70. doi: 10.1016/j.fertnstert.2018.01.035.

  26. García-Solares J, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril 2018; 109: 371-9. doi.org/10.1016/j.fertnstert.2017.12.030

  27. Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol 2017; 40: 68-81. doi:10.1016/j.bpobgyn.2016.09.006

  28. Gordts S, et al. Symptoms and classification of uterine adenomyosis. Fertil Steril 2018; 109: 380-8. doi.org/10.1016/j. fertnstert.2018.01.006

  29. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril 2018; 109: 389-97. doi. org/10.1016/j.fertnstert.2018.01.024

  30. Champaneria R, et al. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand 2010; 89: 1374-84. doi: 10.3109/00016349.2010.512061

  31. Lasmar RB, Lasmar BP. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB). Best Pract Res Clin Obstet Gynaecol. 2017; 40: 82-88. doi: 10.1016/j. bpobgyn.2016.09.008

  32. Islam MS, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab. 2013; 98 (3): 921-34. doi: 10.1210/ jc.2012-3237

  33. Stewart EA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017; 124 (10): 1501-12. doi: 10.1111/1471-0528.14640

  34. Styer AK, Rueda BR. The epidemiology and genetics of uterine leiomyoma. Best Practice & Research Clinical Obstetrics and Gynaecology 2016; 34: 3-12. doi: 10.1016/j. bpobgyn.2015.11.018

  35. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 54-65. doi: 10.1016/j.bpobgyn.2015.11.012.

  36. Sepúlveda J, Alarcón MA. Manejo médico de la miomatosis uterina. Revisión de la literatura. Rev Chil Obstet Ginecol 2016; 81 (1): 48-55. doi:10.4067/S0717- 75262016000100009

  37. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008; 112 (2 Pt 1): 387-400. doi: 10.1097/AOG.0b013e318183fbab

  38. Reis FM, et al. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 13-24. doi: 10.1016/j.bpobgyn.2015.11.015

  39. Islam MS, et al. Growth factors and pathogenesis. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 25-36. doi: 10.1016/j.bpobgyn.2015.08.018

  40. Van Voorhis BJ, et al. Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med 2002; 47: 663-9.

  41. Dueholm M, Hjorth IM. Structured imaging technique in the gynecologic office for the diagnosis of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 23-43. doi: 10.1016/j.bpobgyn.2016.09.010

  42. Van den Bosch T, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015; 46 (3): 284-98. doi: 10.1002/uog.14806

  43. Parkash V, et al. Committee Opinion No. 631: Endometrial Intraepithelial Neoplasia. Obstet Gynecol 2015; 126 (4): 897. doi: 10.1097/AOG.0000000000001071

  44. Emons G, et al. New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd. 2015; 75 (2): 135-6. doi.10.1055/s-0034-1396256

  45. Adams T, Denny L. Abnormal vaginal bleeding in women with gynaecological malignancies. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 134-47. doi: 10.1016/j.bpobgyn. 2016.09.014

  46. Van Hanegem N, et al. The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2016; 197: 147-55. doi: 10.1016/j.ejogrb.2015.12.008

  47. ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women with Postmenopausal Bleeding. Obstet Gynecol. 2018; 131(5): e124-e129. doi: 10.1097/AOG.0000000000002631.

  48. Practice bulletin no. 128: Diagnosis of Abnormal Uterine Bleeding in Reproductive-Aged Women. Obstet Gynecol.2012; 120: 197-206. doi: 10.1097/ AOG.0b013e318262e320.

  49. Committee on Adolescent Health Care; Committee on Gynecologic Practice. Committee Opinion No.580: Von Willebrand Disease in Women. Obstet Gynecol. 2013; 122: 1368-73. doi: 10.1097/01.AOG.0000438961.38979.19.

  50. Kouides PA, et al. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005; 84: 1345-51. doi: 10.1016/j. fertnstert.2005.05.035

  51. Shankar M, et al. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004; 111: 734-40. doi: 10.1111/j.1471-0528.2004.00176.x

  52. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009 Jul;201(1):12.e1-8. doi: 10.1016/j. ajog.2009.04.024

  53. Committee on Practice Bulletins—Gynecology. Management of Abnormal Uterine Bleeding Associated With Ovulatory Dysfunction. Obstet Gynecol. 2013 Jul;122(1):176-85. doi: 10.1097/01. doi: 10.1097/01.AOG.0000431815.52679. bb

  54. Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynecology and Obstetrics 2011; 113:3-13. doi:10.1016/j.ijgo.2010.11.011

  55. Spremović-Rađenović S, Stefanović A, Kadija S, Jeremić K, Sparić R. Classification and the diagnostics of abnormal uterine bleeding in nongravid women of reproductive age: The PALM-COEIN classification system adopted by the International Federation of Gynecology and Obstetrics. Vojnosanit Pregl. 2016;73(12):1154-9. doi: 10.2298/ VSP160709289S

  56. Madhra M, Fraser IS, Munro MG, Critchley HO. Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Acta Obstet Gynecol Scand. 2014;93(7):619-25. doi: 10.1111/aogs.12390

  57. Töz E, Sancı M, Özcan A, Beyan E, İnan AH. Comparison of classic terminology with the FIGO PALM-COEIN system for classification of the underlying causes of abnormal uterine bleeding. Int J Gynaecol Obstet. 2016;133(3):325-8. doi:10.1016/j.ijgo.2015.09.033

  58. Mishra D, Sultan S. FIGO’s PALM–COEIN Classification of Abnormal Uterine Bleeding: A Clinico-histopathological Correlation in Indian Setting The Journal of Obstetrics and Gynecology of India 2017;67(2):119–125. doi: 10.1007/ s13224-016-0925-8




2020     |     www.medigraphic.com